March 20 2022

Algae-Based Pain Medication

Cawthron Institute develop world’s first algae-based local anaesthetic

Cawthron Institute in New Zealand and researchers at Boston Children’s Hospital are contributing to a major global scientific innovation that is supporting the development of the world’s first algae-based pain medication. Learn more about this breakthrough research and see Industrial Plankton photobioreactors in use here.

Check out a recording of the Annual Thomas Cawthron Memorial Lecture. A few shots of our bioreactors can be seem at the 52 and 55 minute mark of the recorded live-stream event.

Cawthron Bioreactors algae-based pain medication
Image credit: Cawthron Institute